2008 Clinical Practice Guidelines - Canadian Diabetes Association

high dietary fiber intake in patients with type 2 diabetes mellitus.
N Engl J Med. 2000;342:1392-1398.
37. Cooper PL, Wahlqvist ML, Simpson RW. Sucrose versus saccharin
as an added sweetener in non-insulin-dependent diabetes:
short- and medium-term metabolic effects. Diabet Med.
1988;5:676-680.
38. Chantelau EA, Gösseringer G, Sonnenberg GE, et al.
Moderate intake of sucrose does not impair metabolic control
in pump-treated diabetic out-patients. Diabetologia. 1985;28:
204-207.
39. Colagiuri S, Miller JJ, Edwards RA. Metabolic effects of
adding sucrose and aspartame to the diet of subjects with noninsulin-dependent
diabetes mellitus. Am J Clin Nutr. 1989;50:
474-478.
40. Coulston AM, Hollenbeck CB, Donner CC, et al. Metabolic
effects of added dietary sucrose in individuals with noninsulindependent
diabetes mellitus (NIDDM). Metabolism. 1985;34:
962-966.
41. Jellish WS, Emanuele MA, Abraira C. Graded sucrose/carbohydrate
diets in overtly hypertriglyceridemic diabetic patients.
Am J Med. 1984;77:1015-1022.
42. Nutrition Subcommittee of the British Diabetic Association’s
Professional Advisory Committee. Sucrose and fructose in the
diabetic diet. Diabet Med. 1990;7:764-769.
43. Hawkins M, Gabriely I, Wozniak R, et al. Fructose improves
the ability of hyperglycemia per se to regulate glucose production
in type 2 diabetes. Diabetes. 2002;51:606-614.
44. Henry RR, Crapo PA,Thorburn AW. Current issues in fructose
metabolism. Annu Rev Nutr. 1991;11:21-39.
45. Wang YM, van Eys J. Nutritional significance of fructose and
sugar alcohols. Annu Rev Nutr. 1981;1:437-475.
46. Wolever TMS, Piekarz A, Hollands M, et al. Sugar alcohols and
diabetes: a review. Can J Diabetes. 2002;26:356-362.
47. Wolever T, Barbeau M-C, Charron S, et al. Guidelines for the
nutritional management of diabetes mellitus in the new millennium:
a position statement by the Canadian Diabetes
Association. Can J Diabetes Care. 1999;2:56-69.
48. Franz MJ, Bantle JP, Beebe CA, et al. Evidence-based nutrition
principles and recommendations for the treatment and prevention
of diabetes and related complications. Diabetes Care.
2002;25:148-198.
49. Jackson AA. Limits of adaptation to high dietary protein
intakes. Eur J Clin Nutr. 1999;53(suppl 1):S44-S52.
50. National Cholesterol Education Program. Second Report of
the Expert Panel on Detection, Evaluation, and Treatment of
High Blood Cholesterol in Adults (Adult Treatment Panel II).
Circulation. 1994;89:1333-1445.
51. Expert Panel on Detection, Evaluation, and Treatment of High
Blood Cholesterol in Adults. Executive Summary of The Third
Report of The National Cholesterol Education Program
(NCEP) Expert Panel on Detection, Evaluation, and Treatment
of High Blood Cholesterol in Adults (Adult Treatment Panel
III). JAMA. 2001;285:2486-2497.
52. de Lorgeril M, Salen P, Martin JL, et al. Mediterranean diet,
traditional risk factors, and the rate of cardiovascular complications
after myocardial infarction: final report of the Lyon
Diet Heart Study. Circulation. 1999;99:779-785.
53. Hu FB, Cho E, Rexrode KM, et al. Fish and long-chain omega-
3 fatty acid intake and risk of coronary heart disease and total
mortality in diabetic women. Circulation. 2003;107:1852-1857.
54. Grundy SM, Abate N, Chandalia M. Diet composition and the
metabolic syndrome: what is the optimal fat intake? Am J Med.
2002;113(suppl 9B):25S-29S.
55. Howard BV. Dietary fat and diabetes: a consensus view. Am J
Med. 2002;113(suppl 9B):38S-40S.
56. Garg A. High-monounsaturated-fat diets for patients with diabetes
mellitus: a meta-analysis. Am J Clin Nutr. 1998;67(suppl
3):577S-582S.
57. Ros E. Dietary cis-monounsaturated fatty acids and metabolic
control in type 2 diabetes. Am J Clin Nutr. 2003;78(suppl 3):
617S-625S.
58. Heart Protection Study Collaborative Group. MRC/BHF
Heart Protection Study of antioxidant vitamin supplementation
in 20,536 high-risk individuals: a randomised placebocontrolled
trial. Lancet. 2002;360:23-33.
59. Rapola JM, Virtamo J, Ripatti S, et al. Randomised trial of
alpha-tocopherol and beta-carotene supplements on incidence
of major coronary events in men with previous myocardial
infarction. Lancet. 1997;349:1715-1720.
60. Yusuf S, Dagenais G, Pogue J, et al.Vitamin E supplementation
and cardiovascular events in high-risk patients. The Heart
Outcomes Prevention Evaluation Study Investigators. N Engl J
Med. 2000;342:154-160.
61. Omenn GS, Goodman GE,Thornquist MD, et al. Risk factors
for lung cancer and for intervention effects in CARET, the
Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst.
1996;88:1550-1559.
62. Ashley MJ, Ferrence R, Room R, et al. Moderate drinking and
health. Implications of recent evidence. Can Fam Physician.1997;
43:687-694.
63. Bondy SJ, Rehm J, Ashley MJ, et al. Low-risk drinking guidelines:
the scientific evidence. Can J Public Health. 1999;90:264-
270.
64. Burge MR, Zeise TM, Sobhy TA, et al. Low-dose ethanol predisposes
elderly fasted patients with type 2 diabetes to sulfonylurea-induced
low blood glucose. Diabetes Care. 1999;22:
2037-2043.
65. Richardson T, Weiss M, Thomas P, et al. Day after the night
before: influence of evening alcohol on risk of hypoglycemia in
patients with type 1 diabetes. Diabetes Care. 2005;28:1801-
1802.
66. Turner BC, Jenkins E, Kerr D, et al.The effect of evening alcohol
consumption on next-morning glucose control in type 1
diabetes. Diabetes Care. 2001;24:1888-1893.
67. Kerr D, Macdonald IA, Heller SR, et al. Alcohol causes hypoglycaemic
unawareness in healthy volunteers and patients with
type 1 (insulin-dependent) diabetes. Diabetologia. 1990;33:
216-221.
S45
MANAGEMENT